Big data in the pharmaceutical industry can provide several benefits: 1) Cost savings through more efficient R&D, manufacturing and marketing processes. 2) Developing new and better product offerings by leveraging real-world data on patient outcomes. 3) More targeted marketing by identifying specific patient segments. Big data also enables profit maximization through cross-selling and up-selling tailored products, as well as the development of new business models in healthcare.

1. Big Data in Pharmaceutische Industrie
drs. Katherine Kucherenko
Digital Power

7. Cloud technology Mobile Internet
Internet of Things 3D Printing

14. 1. Kostenbesparing

17. 2. Nieuwe/betere proposities

19. 3. Targeting

22. 4. Winstmaximalisatie d.m.v. cross-
selling & up-sell

28. 5. Nieuwe business modellen

31. “Innovations that expand
markets will almost
always come from
outside the industry”
Albert Einstein

33. Jaar Omzet Groei
2008 16, 4 mln
2009 33,3 mln 103%
2010 100 mln 200%
2011 114 mln 14%
2012 168 mln 48%
2013 248 mln 48%
2014 > 300 mln

34. Jaar Omzet Groei
2008 16,4 mln
2009 33,3 mln + 14%
2010 100 mln + 200%
2011 114 mln + 14%
2012 168 mln + 48%
2013 248 mln + 48%
2014 > 300 mln
Data Value Chain

37. Data is the new oil

38. Data is the new Soil

39. Prof.dr. Henry Robben & Prof.dr. Rudy Moenaert

42. Drs. Katherine Kucherenko
Digital Business Strategist
Digital Power
katherine.kucherenko@digital-power.com